SANA · Sana Biotechnology, Inc.
$3.16
+0.02 (+0.64%)
At close · Jul 21
Going-concern doubt
— flagged May 11, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Management has determined that the Company’s current capital resources may not be sufficient to fund its planned operations for at least one year from the date of this Quarterly Report, and there is substantial doubt as to the Company's ability to continue as a going concern.”View the 10-Q filed May 11, 2026
Market Cap
$879.40M
Shares
278.29M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Steven D. Harr | CEO | $2,903,010 |
| Bernard J. Cassidy | General Counsel | $1,016,113 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Steven D. Harr | CEO | $8,788,580 |
| Nathan Hardy | CFO | $3,050,230 |
| Douglas E. Williams | Former Executive Vice President and President, Research and Development | $2,754,070 |
| Bernard J. Cassidy | General Counsel | $2,345,597 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Douglas E. Williams | Former Executive Vice President and President, Research and Development | $3,044,751 |
| Steven D. Harr | CEO | $2,671,662 |
| Nathan Hardy | CFO | $1,185,767 |
| Bernard J. Cassidy | General Counsel | $987,382 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Bernard J. Cassidy | General Counsel | $3,954,327 |
| Steven D. Harr | Board Member | $3,807,979 |
| Sunil Agarwal | Executive Vice President, Head of Development, and Chief Medical Officer | $1,659,608 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Sunil Agarwal | Executive Vice President, Head of Development, and Chief Medical Officer | $1,928,519 |
| Steven D. Harr | Board Member | $1,186,154 |
| Nathan Hardy | CFO | $683,493 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Steven D. Harr | CEO | $6,845,197 |
Key facts
CIK
1770121
CUSIP
799566104
13F (30d)
17 filings
17 filers
Visit website
Investor relations